Figure 2. Therapeutic Response/serum Alkaline Phosphatase (sap) Normalization Over Time (Zoledronic Acid Fig1)
Zoledronic Acid Injection, Solution
Product Images NDC 55150-283
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 55150-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label-principal Display Panel (5 mg per 100 mL (0.05 mg / mL))
This is a package insert for Zoledronic Acid Injection, a medication used to treat high levels of calcium in the blood. The injection contains 5 mg of zoledronic acid and is administered intravenously over a period of at least 15 minutes. The medication should not be mixed with calcium-containing solutions and should be stored at a controlled room temperature. For more information, contact the manufacturer.*
Package Label-principal Display Panel (5 mg per 100 mL (0.05 mg / mL))
Zoledronic Acid Injection is a drug administered as a sterile solution for intravenous infusion. It comes in a bottle and should not be mixed with calcium-containing solutions. It is distributed by AuroMedics Pharma LLC, and made in India. Each bottle contains 5mg per 100 mL of zoledronic acid monohydrate, equivalent to 5mg zoledronic acid on an anhydrous basis, 4950mg of mannitol, 30mg of sodium citrate, and water for injection qs to 100mL. The pH of the solution is 6.0-7.0. After opening, the solution is stable for 24 hours at 2° to 8°C. Infusion time should not be less than 15 minutes. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Each bottle comes with an accompanying Medication Guide that should be dispensed to each patient.*
Zoledronic Acid Monohydrate Chemical Structure (Zoledronic Acid Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
